Please assess the completion status of the following clinical trial:

Trial Title: EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Non-dialyzed male or female patients with CKD, with a GFR of less than 30mL/min/1.73m² who have elevated serum phosphorus or who develop elevated serum phosphorus following washout from phosphorus-binding therapy.~* Patients must have written informed consent~* Negative serum pregnancy test if appropriate~* Expected to be able to comply with protocol procedures and schedule~Exclusion Criteria:~* Unstable angina pectoris~* Severe congestive heart failure~* Severe liver dysfunction~* Severe malnutrition~* Severe hyperparathyroidism~* AIDS (HIV positive subjects without AIDS are not excluded)~* Active malignancy for which the subject is receiving chemotherapy or radiation~* Subject unlikely to complete the study~* History of obstructed bowels or hypersensitivity to any of the study medications or their components~* History of swallowing disorders such as dysphagia (that would prevent the subject from taking the study drug) severe gastrointestinal motility disorders, or major GI tract surgery~* Participation in an investigational drug or device trial within 30 days of randomization~* Subjects on Vitamin D therapy~* Subjects with acute symptoms, in the last month, or current radiographic evidence of kidney stones~* Subjects who have undergone renal transplant or receiving dialysis~* Or any condition with makes patient participation not in the patients best interest

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PhosLo (Type: EXPERIMENTAL): None
- placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).